Key result
Drug-eluting stents dramatically reduce restenosis in both simple and complex coronary lesions.
Why the study?
Restenosis has limited the success of percutaneous interventional cardiology since 1977, and drug-eluting stents have shown promise in reducing restenosis in various patient populations.
Do drug-eluting stents reduce restenosis in patients undergoing percutaneous coronary intervention?
Do drug-eluting stents reduce restenosis in patients undergoing percutaneous coronary intervention?
Drug-eluting stents significantly reduce restenosis across both simple and complex coronary lesions, increasing their clinical value in real-world practice.
Supports DES use to reduce restenosis in PCI; extends prior reviews but leaves open needs for updated comparative trials.
Since its introduction in 1977, the success of percutaneous interventional cardiology has been limited by the occurrence of restenosis. Drug-eluting stents, particularly sirolimus- and paclitaxel-coated stents, have been shown in randomized controlled trials to dramatically reduce restenosis in single, de novo, native coronary arteries. Over the last 2 years, investigators have reported that these stents can also reduce restenosis in more complex patient situations such as in diabetics, during acute coronary syndromes, in long atherosclerotic lesions and small arteries, and even after in-stent restenosis. These outcomes increase the clinical value of this technology to "real world" practice. This article reviews the current state of our knowledge regarding drug-eluting stents and identifies areas for further research.
No takes yet. Share an insight, caveat, or question.
Julie Stanik-Hutt (2004) conducted a review in Restenosis in coronary arteries. Drug-eluting stents (sirolimus- and paclitaxel-coated) was evaluated on Restenosis. Drug-eluting stents, particularly sirolimus- and paclitaxel-coated stents, dramatically reduce restenosis in both simple and complex coronary artery lesions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: